Pacira Biosciences Inc banner

Pacira Biosciences Inc
F:82P

Watchlist Manager
Pacira Biosciences Inc Logo
Pacira Biosciences Inc
F:82P
Watchlist
Price: 17.7 EUR Market Closed
Market Cap: €823.9m

Wall Street
Price Targets

82P Price Targets Summary
Pacira Biosciences Inc

Wall Street analysts forecast 82P stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 82P is 25.68 EUR with a low forecast of 19.68 EUR and a high forecast of 33.81 EUR.

Lowest
Price Target
19.68 EUR
11% Upside
Average
Price Target
25.68 EUR
45% Upside
Highest
Price Target
33.81 EUR
91% Upside
Pacira Biosciences Inc Competitors:
Price Targets
KRUS
Kura Sushi USA Inc
-7% Downside
SITOWS
Sitowise Group Oyj
6% Upside
LE
Lands End Inc
97% Upside

Revenue
Forecast

34% / Year
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
34% / Year
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

For the last 13 years the compound annual growth rate for Pacira Biosciences Inc's revenue is 34%. The projected CAGR for the next 4 years is 7%.

Operating Income
Forecast

N/A
Past Growth
25% / Year
Estimated Growth
Estimates Accuracy
-50%
Average Miss
N/A
Past Growth
25% / Year
Estimated Growth
Estimates Accuracy
-50%
Average Miss

The compound annual growth rate of Pacira Biosciences Inc's operating income for the next 4 years is 25%.

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-60%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-60%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is 82P's stock price target?
Price Target
25.68 EUR

According to Wall Street analysts, the average 1-year price target for 82P is 25.68 EUR with a low forecast of 19.68 EUR and a high forecast of 33.81 EUR.

What is Pacira Biosciences Inc's Revenue forecast?
Projected CAGR
7%

For the last 13 years the compound annual growth rate for Pacira Biosciences Inc's revenue is 34%. The projected CAGR for the next 4 years is 7%.

What is Pacira Biosciences Inc's Operating Income forecast?
Projected CAGR
25%

The compound annual growth rate of Pacira Biosciences Inc's operating income for the next 4 years is 25%.

Back to Top